AQR Capital Management - CASI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$122,000
-14.7%
38,062
-23.4%
0.00%
Q1 2019$143,000
-54.5%
49,704
-36.4%
0.00%
Q4 2018$314,000
-24.2%
78,129
-11.9%
0.00%
Q3 2018$414,000
-34.1%
88,702
+16.2%
0.00%
-100.0%
Q2 2018$628,00076,3500.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders